AJO LP’s Puma Biotechnology PBYI Stock Holding History

AJO LP’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,738	Closed	-$118K	–	547
2020 Q3	$118K	Buy	+11,738	New	+$120K	﹤0.01%	629

Other funds holding PBYI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AJO LP's PBYI Position: Q4 2020 in Review

AJO LP sold out of Puma Biotechnology (PBYI) in Q4 2020, closing a stake of 11,738 shares — an estimated $118K sold.

AJO LP first reported a position in PBYI in Q3 2020 and held it in 1 quarter. The position peaked at $118K in Q3 2020. 123 funds tracked by Wall St. Rank hold PBYI as of Q4 2020.

AJO LP reported no remaining Puma Biotechnology position as of Q4 2020 after selling out during the quarter.
AJO LP sold 11,738 Puma Biotechnology shares in Q4 2020, an estimated $118K.
AJO LP first reported a position in Puma Biotechnology in Q3 2020 and held it in 1 quarter.
AJO LP's Puma Biotechnology position peaked at $118K in Q3 2020.
123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.